CureVac N.V. (CVAC) Financials
CVAC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 892.0 million | 254.4 million |
2023-06-30 | 978.0 million | 272.3 million |
2023-03-31 | 937.9 million | 356.7 million |
2022-12-31 | 923.4 million | 351.2 million |
CVAC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -78.3 million | 1.8 million |
2023-06-30 | -85.2 million | 3.3 million |
2023-03-31 | -76.0 million | 3.0 million |
2022-12-31 | -74.9 million | 2.9 million |
CVAC Net Income
No data available :(
CVAC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 495.0 million | - | 44.6 million |
2023-06-30 | 590.7 million | - | 44.0 million |
2023-03-31 | 545.3 million | - | 44.8 million |
2022-12-31 | 536.9 million | - | 45.2 million |
CVAC Shares Outstanding
CVAC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 14.2 million | 28.8 million | 16.8 million | 153503 |
2023-06-30 | 15.4 million | 33.6 million | 20.6 million | 95685 |
2023-03-31 | 22.5 million | 30.1 million | 25.7 million | 105730 |
2022-12-31 | 22.2 million | 29.6 million | 25.3 million | 104097 |
CVAC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 17.4 million | 25.7 million |
2023-06-30 | 8.2 million | 28.1 million |
2023-03-31 | 12.7 million | 87.2 million |
2022-12-31 | 12.5 million | 85.9 million |
CVAC
Price: $2.33
52 week price:
Earnings Per Share: -1.59 USD
P/E Ratio: -2.18
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 537100
Market Capitalization: 517.3 million